GerdCare Medical

First-Ever Noninvasive and Drug Free Technology to Treat Gastroesophageal Reflux Disease (GERD)

Health Tech & Life Sciences
Active
Series A Yokne'am Illit, Israel Founded 2017
Last updated 2026-06-18
Total raised
Last: 2025-04
Stage
Series A
Founded
2017
Headcount
2
HQ
Yokne'am Illit, Israel
Sector
Health Tech & Life Sciences

About

GerdCare Medical Ltd, a company pioneering a new era in the global treatment of Gastroesophageal Reflux Disease (GERD). With over 1 billion people affected worldwide—and up to 40% unresponsive to existing drug therapies — GERD remains a critical and underserved health challenge. Current treatments, such as proton pump inhibitors (PPIs) and surgery, either mask symptoms without addressing the underlying cause or involve significant risks and low patient uptake. GerdCare is addressing this unmet clinical need.

Our Breakthrough Solution GerdCare has developed the first-ever wearable, drug-free, non-invasive GERD treatment designed to restore the function of the gastroesophageal barrier—directly targeting the root cause of GERD, not just its symptoms. Our solution includes: • A smart wearable device delivering targeted electrical stimulation • A proprietary mobile app for personalized treatment optimization and tracking • A secure clinician dashboard enabling remote patient monitoring

Clinically Validated Outcomes • Rapid symptom relief by significant reduction / normalization of esophageal acidity and GERD symptoms (such as heartburn and regurgitation) within 3–4 days • Up to 75% reduction in regurgitation, compared to approximately 10% - 15% with standard drug therapy • Excellent safety profile across proof-of-concept and pilot studies • Pivotal, FDA-approved clinical trial currently enrolling patients

Market Opportunity • $6.3B+ global GERD therapeutics market, growing at 3.6% CAGR • 23M refractory patients in the US and EU alone • Razor-and-blade model with recurring consumables revenue • 80% gross margins and strong potential for both medical devices and pharma partnerships

GerdCare holds multiple issued patents in the US, EU, Asia, IL.

Funding history · 2 rounds · — total

2025-04
Undisclosed
2018-01
Undisclosed

Q&A

What is GerdCare Medical's primary focus?
GerdCare Medical is pioneering a new era in the global treatment of Gastroesophageal Reflux Disease (GERD) with a non-invasive, drug-free, wearable technology.
What is GerdCare Medical's breakthrough solution for GERD?
GerdCare Medical has developed the first-ever wearable, drug-free, non-invasive GERD treatment designed to restore the function of the gastroesophageal barrier. This solution includes a smart wearable device, a proprietary mobile app, and a secure clinician dashboard.
What are the clinically validated outcomes of GerdCare Medical's solution?
GerdCare Medical's solution has shown rapid symptom relief within 3–4 days, a significant reduction in esophageal acidity and GERD symptoms, and up to a 75% reduction in regurgitation. It also has an excellent safety profile.
What is the current status of GerdCare Medical's clinical trials?
GerdCare Medical is currently enrolling patients for a pivotal, FDA-approved clinical trial.
What is the estimated market opportunity for GERD therapeutics?
The global GERD therapeutics market is valued at over $6.3 billion and is growing at a 3.6% CAGR, with 23 million refractory patients in the US and EU alone.
What is GerdCare Medical's business model?
GerdCare Medical operates on a razor-and-blade model with recurring consumables revenue, aiming for 80% gross margins and potential for partnerships in both medical devices and pharma.
Does GerdCare Medical hold any patents?
Yes, GerdCare Medical holds multiple issued patents in the US, EU, Asia, and Israel.
When was GerdCare Medical founded?
GerdCare Medical was founded in September 2017.
How many employees does GerdCare Medical have?
GerdCare Medical has 1-10 employees.
Which investor participated in GerdCare Medical's funding rounds?
Alon MedTech Ventures participated in GerdCare Medical's funding rounds in January 2018 and April 2025.

Team · 3

Shimon Eckhouse
Founder · Chairman
Founder · Co-founder & CTO
LinkedIn ↗
Founder · Co-founder & VP R&D

Sectors & technology

Primary sector
Health Tech & Life Sciences
Sub-sectors
Health Tech & Life SciencesMedical DevicesMedical Treatment & Therapeutics
Technologies
Platforms & InterfacesMobile
Target customers
Healthcare & Life SciencesHealthcarePatientsProviders
Business model
B2B2CB2C

Highlights

1 PatentsVerified

Tags

non-invasivewearabletreatmentsmedical-devicesgastroenterologychronic-disease
Full data — links, identifiers, deals & radar signals (jobs, patents, research, more)

External links

Websitegerd-care.com/
LinkedInlinkedin.com/company/69738892

Identifiers & details

Founded2017-9
Employees (exact)2

Radar intelligence

Patents

EPO3

Web history (Wayback)

Domaingerd-care.com

Certificate / subdomain footprint

Subdomains1